Of respondents, 92 percent are not interested in expanding patient-reported outcome measures in clinical trials.
Concerning HEOR measures, drug companies often fund research, leading many payers to questions its validity. But, approximately 70 percent of executives are confident in HEOR measures when a neutral organization or institution supports the measure.
More articles on coding, billing and collections:
Majority of Americans support ACA in new poll: 3 insights
Trump administration to maintain ACA’s cost-sharing subsidies to payers during lawsuit: 4 points
The 4 secrets to scaling your business
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
